✦ LIBER ✦

Tumor regression by combination antisense therapy against Plk1 and Bcl-2

✍ Scribed by Elez, Robert; Piiper, Albrecht; Kronenberger, Bernd; Kock, Martin; Brendel, Martin; Hermann, Eva; Pliquett, Uwe; Neumann, Eberhardt; Zeuzem, Stefan

Book ID: 110067170
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 547 KB
Volume: 22
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1206038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of progression to androgen-in

Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense BCL-XL and antisense Bcl-2 oligonucleotides plus taxol after castration in the Shionogi tumor model

✍ Hideaki Miyake; Brett P. Monia; Martin E. Gleave 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 184 KB 👁 2 views

We have reported that antisense Bcl-2 oligodeoxynucleotide (ODN) delays progression to androgen independence in the androgen-dependent (AD) mouse Shionogi tumor model. Here, we characterize changes in bcl-xL, another important anti-apoptotic gene, and test the efficacy of adjuvant antisense Bcl-xL O

Combination chemotherapy employing bispe

Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

✍ Marvin Rubenstein; Paulus Tsui; Patrick Guinan 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 350 KB

Combination of vascular endothelial grow

Combination of vascular endothelial growth factor antisense oligonucleotide therapy and radiotherapy increases the curative effects against maxillofacial VX2 tumors in rabbits

✍ Lin-Feng Zheng; Yu-Jie Li; Han Wang; Jing-Long Zhao; Xi-Fu Wang; Yun-Sheng Hu; G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Systemic delivery of siRNA specific to t

Systemic delivery of siRNA specific to tumor mediated by atelocollagen: Combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer

✍ Ping Mu; Shunji Nagahara; Naoki Makita; Yuzo Tarumi; Kenji Kadomatsu; Yoshifumi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 816 KB

## Abstract The largest obstacle to the effective use of short interfering RNA (siRNA) in an animal body is the ability to deliver it to the target tissue. Here we showed a systemic delivery method of siRNA specific to pregrown solid tumors __via__ atelocollagen. Atelocollagen facilitated the selec

172 P - Inhibition of BCL-2 by antisense

172 P - Inhibition of BCL-2 by antisense oligonucleotides reduces tumor size and reduces chemotesistance of human melanoma in SCID mice

✍ B. Jansen; H. Wadl; S.A. Inoue; B. Brown; B. Bryan; H.-G. Eichler; K. Wolff; H. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Synergistic chemosensitization and inhib

Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model

✍ Simon Leung; Hideaki Miyake; Tobias Zellweger; Anthony Tolcher; Martin E. Gleave 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 111 KB 👁 1 views